Loading...
•
Sep 30, 2022
PROCEPT BioRobotics Q3 2022 Earnings Report
Reported strong third quarter results driven by increased U.S. revenues and system sales, and increased fiscal year 2022 total revenue guidance.
Key Takeaways
PROCEPT BioRobotics reported a strong third quarter with total revenue of $20.3 million, a 135% increase compared to the prior year period. The company increased its fiscal year 2022 total revenue guidance to approximately $72.5 million, representing 110% growth compared to 2021.
Total Revenue of $20.3 million for the third quarter of 2022, an increase of 135% compared to the prior year period
U.S. system and rental revenue of $9.8 million for the third quarter of 2022, an increase of 95% compared to the prior year period
U.S. handpiece and consumables revenue of $8.0 million for the third quarter of 2022, an increase of 267% compared to the prior year period
Increased fiscal year 2022 total revenue guidance to approximately $72.5 million, representing growth of 110% compared to 2021
PROCEPT BioRobotics
PROCEPT BioRobotics
PROCEPT BioRobotics Revenue by Segment
PROCEPT BioRobotics Revenue by Geographic Location
Revenue by Segment
U.S. System Sales & Rentals Revenue
CapyFin.comU.S. Handpieces & Consumables Revenue
CapyFin.comInternational System Sales & Rentals Revenue
CapyFin.comInternational Handpieces & Consumables Revenue
CapyFin.comRevenue by Geographic Location
U.S. Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
The Company projects revenue for the full year 2022 to be approximately $72.5 million, which represents 110% growth over the Company’s prior year revenue. The Company projects full year 2022 Gross Margin guidance to be in the range 50% to 51%.
Revenue & Expenses
Visualization of income flow from segment revenue to net income